申请人:MICROBIAL CHEMISTRY RESEARCH FOUNDATION
公开号:EP0241797A2
公开(公告)日:1987-10-21
The present invention relates to novel Spergualin-related compounds represented by the general formula [I]
R2 is a residue obtained by removing, from an amino acid or peptide, the hydroxyl group of the carboxyl group and, when R, is a group other than -H, R2 is same as R, , or a pharmacologically acceptable salt thereof. Said compounds or salts thereof have an immune-modulating action.
The invention further relates to pharmaceutical formulations having an immuno-modulating activity which contain such Spergualin-related compounds and a process for the manufacture of these compounds and preparations.
本发明涉及由通式[I]表示的新型 Spergualin 相关化合物
R2 是通过从氨基酸或肽中去除羧基的羟基而得到的残基,当 R 是除-H 以外的基团时,R2 与 R 相同,或其药理上可接受的盐。上述化合物或其盐具有免疫调节作用。
本发明还涉及具有免疫调节活性的药物制剂,其中含有此类与 Spergualin 相关的化合物,以及制造这些化合物和制剂的工艺。